These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2574496)

  • 41. Effects on physical performance of intrinsic sympathomimetic activity (ISA) during selective beta 1-blockade.
    Kullmer T; Kindermann W; Singer M
    Eur J Appl Physiol Occup Physiol; 1987; 56(3):292-8. PubMed ID: 2883003
    [TBL] [Abstract][Full Text] [Related]  

  • 42. K+ shifts of skeletal muscle during stepwise bicycle exercise with and without beta-adrenoceptor blockade.
    Hallén J; Gullestad L; Sejersted OM
    J Physiol; 1994 May; 477(Pt 1):149-59. PubMed ID: 8071881
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of beta-adrenoceptor blockade on exercise performance and metabolism.
    Lundborg P; Aström H; Bengtsson C; Fellenius E; von Schenck H; Svensson L; Smith U
    Clin Sci (Lond); 1981 Sep; 61(3):299-305. PubMed ID: 7261552
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of CGP 17/582, a selective beta-adrenoceptor antagonist, on the haemodynamic and hypokalaemic response to adrenaline.
    Whyte KF; De Vane PJ; Whitesmith R; Kelman A; Reid JL
    Br J Clin Pharmacol; 1989 May; 27(5):553-61. PubMed ID: 2569322
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metabolic aspects of maximal exercise performance after slow release metoprolol and after atenolol.
    Folgering HT; Borm JF; van Haaren RH
    Eur J Clin Pharmacol; 1982 Oct; 23(4):283-8. PubMed ID: 7173299
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cardio-protection afforded by β-blockade is maintained during resistance exercise.
    Conviser JM; Ng AV; Rockey SS; Thomas DP
    J Sci Med Sport; 2017 Feb; 20(2):196-201. PubMed ID: 27012728
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of topical timolol vs betaxolol on cardiopulmonary exercise performance in healthy volunteers.
    Dickstein K; Hapnes R; Aarsland T; Kristianson K; Viksmoen L
    Acta Ophthalmol (Copenh); 1988 Aug; 66(4):463-6. PubMed ID: 2904203
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term effect of beta-blockade with timolol on maximal work capacity following myocardial infarction.
    Rønnevik PK; Gundersen T; Abrahamsen AM
    Eur Heart J; 1983 Nov; 4(11):773-80. PubMed ID: 6360689
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cardiovascular effects of ophthalmic timolol.
    Leier CV; Baker ND; Weber PA
    Ann Intern Med; 1986 Feb; 104(2):197-9. PubMed ID: 3946944
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of beta-adrenergic blockade on exercise performance in patients with chronic atrial fibrillation.
    Atwood JE; Sullivan M; Forbes S; Myers J; Pewen W; Olson HG; Froelicher VF
    J Am Coll Cardiol; 1987 Aug; 10(2):314-20. PubMed ID: 2885354
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of beta-blockade on plasma potassium concentrations and muscle excitability following static exercise.
    Unsworth K; Hicks A; McKelvie R
    Pflugers Arch; 1998 Aug; 436(3):449-56. PubMed ID: 9644229
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Haemodynamic and metabolic responses to prolonged exercise after chronic beta 1-adrenoceptor blockade in hypertensive man.
    Frisk-Holmberg M; Juhlin-Dannfelt A; Aström H
    Clin Physiol; 1985 Jun; 5(3):231-42. PubMed ID: 2860992
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of ICI 141,292 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man.
    Pringle TH; O'Connor PC; McNeill AJ; Finch MB; Riddell JG; Shanks RG
    Br J Clin Pharmacol; 1986 Mar; 21(3):249-58. PubMed ID: 2870732
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serum potassium concentrations following succinylcholine in patients undergoing beta-adrenoceptor blocking therapy.
    From RP; Mehta MP; Pathak D
    J Clin Anesth; 1989; 1(5):350-3. PubMed ID: 2576378
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Double-blind, randomized, placebo-controlled study of molsidomine in patients with stable effort angina receiving beta-blocker therapy with atenolol.
    De Backer GG; Derese A
    Am Heart J; 1985 Mar; 109(3 Pt 2):678-81. PubMed ID: 3883735
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of cardiac beta 2-receptors in cardiac responses to exercise in cardiac transplant patients.
    Leenen FH; Davies RA; Fourney A
    Circulation; 1995 Feb; 91(3):685-90. PubMed ID: 7828294
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cardiorespiratory alterations consequent to endurance exercise training during chronic beta-adrenergic blockade with atenolol and propranolol.
    Wilmore JH; Ewy GA; Freund BJ; Hartzell AA; Jilka SM; Joyner MJ; Todd CA; Kinzer SM; Pepin EB
    Am J Cardiol; 1985 Apr; 55(10):142D-148D. PubMed ID: 3993546
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of an acute beta-adrenergic blockade on the blood glucose response during lactate minimum test.
    Júnior PB; Neiva CM; Denadai BS
    J Sci Med Sport; 2001 Sep; 4(3):257-65. PubMed ID: 11702913
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of the effects of aqueous and gellan ophthalmic timolol on peak exercise performance in middle-aged men.
    Dickstein K; Aarsland T
    Am J Ophthalmol; 1996 Apr; 121(4):367-71. PubMed ID: 8604729
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of beta 1- vs. beta 1 + beta 2-blockade on exercise endurance and muscle metabolism in humans.
    Cleroux J; Van Nguyen P; Taylor AW; Leenen FH
    J Appl Physiol (1985); 1989 Feb; 66(2):548-54. PubMed ID: 2565329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.